
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology |
Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Osaka 565-0871 [Y. M., H. Y., Y. F., M. O., Y. S., M. S., H. S., M. M.]; Department of Surgery, Kansai Rosai Hospital, Hyogo 660-0064, [N. T.]; and Department of Pathology, School of Allied Health Science, Faculty of Medicine, Osaka University, Osaka 565-0871 [N. M.], Japan
To provide a detailed assessment of micrometastases of colorectal cancer by anatomical mapping of regional lymph nodes (LNs), we analyzed 237 LNs from 11 patients with colorectal cancer by reverse transcription-PCR (RT-PCR) using carcinoembryonic antigen and cytokeratin 20 as genetic markers. All dissected LNs were mapped anatomically and subjected to detection assays for micrometastases. Immunohistochemical analysis was also performed using anti-pancytokeratin antibody AE1/AE3 to confirm the existence of occult cancer cells. By histological analysis, 20 of 237 LNs contained metastatic cells, and they were all positive by both immunohistochemistry and RT-PCR. Of the 217 histologically negative LNs, 14 (6.5%) harbored micrometastases by immunohistochemistry, and 57 (26.2%) were positive for at least one of the two genetic markers. Lymphatic mappings of all patients showed that micrometastases were distributed not only at the pericolic LNs but often at distant LNs. Clinical follow-up study showed that two patients developed recurrence within 1 year after surgery, and both of them had RT-PCR-positive micrometastases in not less than 70% of LNs examined. Moreover, both patients had frequent micrometastases at distant LNs, i.e., those around the root or along the inferior mesenteric artery, when compared with patients with no recurrence. Our findings suggest that genetic diagnosis using the RT-PCR method may be clinically useful along with conventional pathological diagnosis, especially when micrometastases spread to distant LNs.
This article has been cited by other articles:
![]() |
S. Benlloch, J. M. Galbis-Caravajal, C. Alenda, F. M. Peiro, M. Sanchez-Ronco, J. M. Rodriguez-Paniagua, B. Baschwitz, E. Rojas, and B. Massuti Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases Ann. Onc., January 1, 2009; 20(1): 91 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Greene, A. K. Stewart, and H. J. Norton New Tumor-Node-Metastasis Staging Strategy for Node-Positive (stage III) Rectal Cancer: An Analysis J. Clin. Oncol., May 15, 2004; 22(10): 1778 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Feezor, E. M. Copeland III, and S. N. Hochwald Significance of Micrometastases in Colorectal Cancer Ann. Surg. Oncol., December 1, 2002; 9(10): 944 - 953. [Full Text] [PDF] |
||||
![]() |
S. Noura, H. Yamamoto, T. Ohnishi, N. Masuda, T. Matsumoto, O. Takayama, H. Fukunaga, Y. Miyake, M. Ikenaga, M. Ikeda, et al. Comparative Detection of Lymph Node Micrometastases of Stage II Colorectal Cancer by Reverse Transcriptase Polymerase Chain Reaction and Immunohistochemistry J. Clin. Oncol., October 15, 2002; 20(20): 4232 - 4241. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Noura, H. Yamamoto, Y. Miyake, B. no Kim, O. Takayama, I. Seshimo, M. Ikenaga, M. Ikeda, M. Sekimoto, N. Matsuura, et al. Immunohistochemical Assessment of Localization and Frequency of Micrometastases in Lymph Nodes of Colorectal Cancer Clin. Cancer Res., March 1, 2002; 8(3): 759 - 767. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |